Moderate

Mitral stenosis (rheumatic) (MS)

Valvular heart disease · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Almost always rheumatic: fibrosis/fusion of the mitral valve obstructs LA-to-LV flow, raising LA and pulmonary pressures. Common in South Asia and in migrant/older populations in the UK. AF and pregnancy are major decompensators. Percutaneous balloon mitral valvuloplasty (PBMV) is first-line for suitable anatomy.

Red flags

  • New rapid AF with acute pulmonary oedema (loss of diastolic filling time)
  • Haemoptysis
  • Systemic embolism / stroke (LA thrombus)
  • Pregnancy with severe MS and decompensation
  • Right heart failure / severe pulmonary hypertension

Assessment

Differential diagnosis

  • Left atrial myxoma / ball-valve thrombus
  • Cor triatriatum
  • Severe MAC (mitral annular calcification) with functional stenosis
  • Pulmonary hypertension of other cause
  • HFpEF
  • Atrial septal defect / Lutembacher

Investigations

  • Echocardiogram — mitral valve area (severe <=1.5 cm2), mean gradient, PA pressure, Wilkins score for PBMV suitability, LA/LAA thrombus (TOE)
  • ECG (AF, P-mitrale, RV strain), CXR (LA enlargement, pulmonary congestion)
  • Assess for LA/appendage thrombus by TOE before PBMV or cardioversion
  • Exercise echo if symptoms/severity discordant
  • Rheumatic workup where relevant; pregnancy test in women of childbearing age

Management

  • Grade severity (valve area, gradient, PA pressure) and assess PBMV suitability (Wilkins score, no significant MR, no LA thrombus)
  • Rate-control AF (atrial kick less relevant; slower rate lengthens diastole and improves filling) and anticoagulate
  • Decongest with diuretics; treat the tachycardia that often precipitates pulmonary oedema
  • Refer for percutaneous balloon mitral valvuloplasty if symptomatic severe MS with favourable anatomy and no LA thrombus/significant MR
  • Surgical commissurotomy or valve replacement if PBMV unsuitable
  • Rheumatic secondary prophylaxis (penicillin) and pregnancy counselling/planning

Drugs & doses

Rate control: bisoprolol 2.5-5 mg PO once daily OR verapamil/diltiazem to slow HR and lengthen diastole
Digoxin 125-250 mcg PO once daily for AF rate control if needed [renal dose-adjust]
Anticoagulation — WARFARIN (target INR 2-3) is required for AF with rheumatic/moderate-severe MS; DOACs NOT recommended in rheumatic MS with AF (INVICTUS)
Furosemide 20-40 mg PO once/twice daily for pulmonary congestion
Benzathine penicillin G 1.2 million units IM every 3-4 weeks (rheumatic secondary prophylaxis) [paeds <27 kg: 0.6 MU]
In pregnancy: beta-blocker (metoprolol/bisoprolol) + diuretic; avoid hypotension; plan PBMV if severe symptomatic [verify, specialist]

Disposition

Outpatient cardiology follow-up with serial echo; admit for decompensation, fast AF, embolism or pregnancy complications. Refer suitable severe cases for PBMV.

Complications & pitfalls

  • Atrial fibrillation and systemic thromboembolism / stroke
  • Pulmonary hypertension and right heart failure
  • Pulmonary oedema (esp. with tachycardia, pregnancy, fever)
  • Haemoptysis
  • Infective endocarditis
  • Hoarseness (Ortner syndrome) from LA compression of recurrent laryngeal nerve

Exam pearls

  • Rheumatic MS with AF is one of the few remaining firm indications for WARFARIN over DOACs — INVICTUS showed DOAC inferiority.
  • Tachycardia is the enemy: shortening diastole raises LA pressure — rate control is therapeutic, not just symptomatic.
  • Pregnancy doubles cardiac output and commonly unmasks/decompensates MS in the 2nd-3rd trimester; PBMV can be done in pregnancy if needed.
  • PBMV is first-line for pliable non-calcified valves without significant MR or LA thrombus (low Wilkins score).

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.